RxDoctor Payments Data

Steven Dailey, MD

Orthopaedic Surgery · Seaside, ORNPI 1255751921

Payments from drug & device makers

What this record shows

This record is dominated by education: $40,156 of the $43,189 with a category attached, or 93.0%. Smith+Nephew accounts for 88.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $21,950 and has fallen 99.9% since, to $30 in 2025. Among orthopaedic surgery clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,189in general payments, 2019–2025

Across 34 payments — averaging $1270.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$38K
  • Steelhead Surgical Inc$2K
  • Heraeus Medical, LLC.$1K
  • Arthrex$529
  • Zimmer Biomet$486
  • Stryker$402
  • plus $131 from 2 others

What the payments were for

  • Travel & lodging$1,4263%
  • Food & beverage$1,6074%
  • Education$40,15693%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,189 in reported general payments places this provider in the 90th percentile of 228 orthopaedic surgery providers in Oregon.

See all orthopaedic surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$27,941
Medicare patients
29
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib35$1,404
Oxycodone Hcl36$204
Ondansetron OdtOndansetron23$177

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Seaside

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →